
A review article written by researchers at Imperial College London (United Kingdom) explored the potential of volatile organic compounds (VOCs) as early, non-invasive biomarkers for Parkinson’s disease (PD), a neurodegenerative condition that currently lacks reliable diagnostic tools for early-stage detection. LCGC International spoke to Ilaria Belluomo of Department of Surgery and Cancer, Imperial College London and lead author of the review, about how chromatography and mass spectrometry played a part in the team’s research.


























